The aim of this study was to investigate the role of systemic inflammation by means of the neutrophil-to-lymphocyte ratio (NLR) in men with erectile dysfunction (ED). Complete demographic, clinical, and laboratory data from 279 consecutive men with newly diagnosed ED were analyzed. Health-significant comorbidities were scored with the Charlson Comorbidity Index (CCI). A complete blood count was requested for every man, and the NLR was calculated for every individual. Patients were invited to complete the IIEF questionnaire. Logistic regression models tested the odds (OR, 95% CI) of severe ED (defined as IIEF-EF <11, according to Cappelleri's criteria) after adjusting for age, BMI, comorbidities (CCI >0), metabolic syndrome, NLR, cigarette smoking, and color duplex Doppler ultrasound parameters. Likewise, LNR values were also dichotomized according to the most informative cutoff predicting severe ED using the minimum p value approach. 
INTRODUCTION
Erectile dysfunction (ED) was recently proposed as a proxy of general health status (Salonia et al., 2012) . More specifically, a worse erectile function is associated with a lower general health status in men with ED (Salonia et al., 2012) . ED may significantly increase the risk of cardiovascular disease (CVD), coronary heart disease, stroke, overall atherosclerotic cardiovascular events (Batty et al., 2010; Dong et al., 2011) . Despite this, ED severity was shown to be associated with overall men's health, even irrespective of cardiovascular risk factors (Capogrosso et al., 2017) . Metabolic disorders, cardiovascular comorbidities, and ED are closely related, sharing several pathophysiological factors, including systemic low-grade inflammation (Vlachopoulos et al., 2007) . Erectile function was shown to decline as a function of increasing peripheral blood inflammatory markers, such as fibrinogen, interleukin-6, and high-sensitivity C-reactive protein (Vlachopoulos et al., 2007) . Among the several available markers of systemic inflammation, the neutrophil-to-lymphocyte ratio (NLR) was shown to be prognostically associated with several oncologic, cardiovascular, and inflammatory diseases (Cho et al., 2011; Chandrashekara et al., 2015; Nishida et al., 2017) . However, despite the biological connection between inflammation and ED, NLR role was never inquired in ED patients. Therefore, we aimed at evaluating the prognostic role of NLR in a cohort of white European men evaluated at a single academic center for new-onset ED.
METHODS

Study population
The analyses of this cross-sectional study were based on a cohort of 279 consecutive white European men consecutively assessed at a single academic center for new-onset ED between November 2015 and November 2016. Patients were enrolled if they were ≥ 18. Patients were evaluated with a thorough selfreported medical history, including age and comorbidities. Health-significant comorbidities were scored with the Charlson Comorbidity Index (CCI) (Charlson et al., 1987) . We used the International Classification of Diseases 9th revision because its coding algorithms were used to define the 17 comorbidities that constitute the most widely used CCI score. For the aim of the analysis, CCI was categorized as 0 and ≥1. Body mass index (BMI), defined as weight in kilograms by height in square meters, was measured for every patient.
For the specific purpose of this study, ED was defined as the persistent inability to attain and maintain an erection sufficient to permit satisfactory sexual performance (Yafi et al., 2016) ; moreover, patients were enrolled if they failed at least 50% of four consecutive attempts at sexual intercourse. Likewise, to provide a frame of reference for objectively interpreting psychometric data on sexual functioning, patients were invited to complete the International Index of Erectile Function (IIEF) (Rosen et al., 1997) . To interpret ED severity, we used the IIEF-Erectile Function (IIEF-EF) domain classification as proposed by Cappelleri et al., (1999) . Consequently, severe ED was defined as a IIEF-EF score <11. Moreover, every patient underwent standardized penile color duplex Doppler ultrasound (CDDU) assessment (Sikka et al., 2013) . Venous blood samples were drawn from each patient, and a complete blood count was executed for every man at study entry at the same laboratory at the time of admission, thus including total and differential white blood cell (WBC) counts. Total counts for WBC, neutrophils, and lymphocytes were assessed using an automated blood cell counter. NLR was calculated as the ratio of the neutrophil to lymphocyte counts.
Data collection was performed following the principles outlined in the Declaration of Helsinki; all patients signed an informed consent agreeing to deliver their own anonymous information for future studies.
Statistical analyses
Data are reported as medians and interquartile range (IQR). The statistical analyses consisted of several steps. First, the relationship between NLR and ED severity was graphically explored using the locally weighted scatterplot smoothing (lowess) method to account for possible nonlinear relationship (Bennette & Vickers, 2012) . Second, NLR values were dichotomized according to the most informative cutoff value for the outcome IIEF-EF<11 (namely, severe ED) using the minimum p value approach, as described by Mazumdar & Glassman, (2000) . Third, univariable (UVA) and multivariable (MVA) logistic regression models estimated odds ratios (ORs) and 95% confidence intervals (95% CIs) for the severe ED outcome, including as model covariates NLR, age at diagnosis, BMI, cigarette smoking, comorbidities as scored with the CCI, metabolic syndrome (MetS), mean cavernosal peak systolic velocity (PSV) bilaterally evaluated at penile color duplex Doppler 20 min after intracavernosal PGE1 injection, and venogenic ED defined according to Sikka et al., (2013) . Table 1) . The most informative cutoff value for NLR in predicting severe ED was 3 (p = 0.02; Youden index: 14%). Although median NLR values were similar in men with or without severe ED, the proportion of NLR>3 among men with severe ED was 18/87 (21%) vs. 13/192 (7%) in the remaining cohort. Figure 1 displays the inverse relationship between ED severity and NLR; in the context, the higher the NLR values, the worse the IIEF-EF domain scores. 
RESULTS
DISCUSSION
In this cross-sectional study, we inquired whether low-grade systemic inflammation, quantified by means of NLR, was associated with worse erectile function in men with ED. High NLR values, >3 according to the most informative cutoff found at our analyses, were associated with an increased risk of severe ED, even after accounting for known and established risk factors for ED.
The current findings are in agreement with the hypothesis linking low-grade systemic inflammation to ED (Vlachopoulos et al., 2007) . Low-grade systemic inflammation is an important element of the association between metabolic syndrome, ED, and CAD (Vlachopoulos et al., 2007) . Several blood-derived inflammatory markers, such as high-sensitivity C-reactive protein (hs-CRP), interleukin-1 beta, interleukin-6 (IL-6), and tumor 560 Andrology, 2018, 6, 559-563 necrosis factor alpha (TNF-a), were shown to be inversely correlated to SHIM score in men with ED (Vlachopoulos et al., 2006) . Moreover, hs-CRP and IL-6 levels were found higher in men with ED compared to ED-free controls (Chiurlia et al., 2005; Vlachopoulos et al., 2006) . Overall, NLR is a widely used prognostic index, with applications in oncological, cardiovascular, and inflammatory diseases (Cho et al., 2011; Chandrashekara et al., 2015; Nishida et al., 2017) . Several cutoffs have been proposed, according to the different fields of interest, generally ranging between 2 and 5 (Cho et al., 2011; Chandrashekara et al., 2015; Nishida et al., 2017) . To the best of our knowledge, this is the first study exploring the role of NLR in men with ED.
The link between ED and comorbidities is well-known (Salonia et al., 2012). Erectile dysfunction was shown to anticipate a clinically manifest CAD in a relevant proportion of men (Montorsi et al., 2003) and now is recognized as a major risk factor for development of CAD and cardiovascular events (Guo et al., 2010; Vignozzi et al., 2012; Yamada et al., 2012; Vlachopoulos et al., 2013) . Moreover, ED is recognized as a sentinel of general health status, both considering and irrespective of cardiovascular comorbidities (Salonia et al., 2012; Capogrosso et al., 2017) . Therefore, it is of paramount clinical relevance to identify men at risk of both future cardiac events and health status decline. As several inflammatory biochemical markers were extensively shown to be predictors of future cardiovascular outcomes (Danesh et al., 2005; Lowe, 2005) , the clinical significance of NLR in men with ED may be glaring. Previous studies have found that the NLR is a reliable inflammatory biomarker for the atherosclerotic process and is associated with several clinical cardiovascular outcomes (Brown et al., 2001; Horne et al., 2005) . More specifically, a NLR >3.86, as part of a more complex prognostic score, was associated with an increased 6-mos mortality in men who experienced ST-elevation myocardial infarction (STEMI) (Cho et al., 2011) . More recently, a NLR >3.90 was associated with an increased microcirculatory resistance in men with STEMI, that is, an index of microvascular function.
Several of the pathophysiological mechanisms acting together with low-grade systemic inflammation in fostering both ED and cardiovascular diseases can be intercepted by the NLR. Neutrophils produce and secrete several inflammatory mediators (e.g., myeloperoxidase or MPO, reactive oxygen species), which can be responsible of both myocardial and non-myocardial tissue damages (Hansen, 1995; Nishida et al., 2017) . At this regard, neutrophil-secreted MPO levels were found to be significantly higher in men with arteriogenic ED vs. control individuals and non-arteriogenic ED patients (Dozio et al., 2013) . Conversely, lymphocytes may have a regulatory action on neutrophils (Zhang et al., 1992) . The ratio between high neutrophils and low lymphocytes is thought to simultaneously and better depict the role of these two white blood cell subpopulations, conveying a more thorough information than what could be obtained by focusing on neutrophils alone (Azab et al., 2010) . Endothelial dysfunction is a further relevant component in the pathogenesis of ED (Kaiser et al., 2004; Yafi et al., 2016) . Endothelial dysfunction is not a local phenomenon of the corpora cavernosa, as men with ED were shown to have endothelial dysfunction in other districts as well, even before the development of other overt functional or structural systemic vascular disease (Kaiser et al., 2004; Vardi et al., 2009) . These findings are substantiated by clinical studies suggesting that cavernosal arteries blood flow is inversely associated with the risk of experiencing major cardiovascular events (Corona et al., 2008 (Corona et al., , 2010 .
Moreover, ED independently predicted endothelial dysfunction among middle-aged men presenting for wellness screening (Peyton et al., 2016 ). An association between NLR and endothelial dysfunction was previously reported in men with pulmonary thromboembolism (Kurtipek et al., 2017) . As a whole, high NLR emerges as an epiphenomenon of a plethora of factors contributing to ED onset and maintenance, thus involving inflammation, vascular alterations, tissue damage, and endothelial dysfunction. Nonetheless, a pro-inflammatory hormonal milieu could alter both erectile function and NLR (Vignozzi et al., 2012) . The possible role of NLR in capturing all these features makes it a powerful candidate marker for assessment of both sexual health and cardiovascular risk in male patients; thereof, further studies are definitely needed at this regard, as well as for the female counterpart (Vignozzi et al., 2012) .
Our study is not devoid of limitations. First, this was a hospital-based study, raising the possibility of a number of selection biases. Patients were recruited from a single tertiary referral academic outpatient clinic; therefore, larger studies across different centers and populations will be needed to substantiate our findings. Second, the cross-sectional design does not allow to draw conclusions on the overall diagnostic role of NLR in ED due to the lack of same-race, age-matched cohort of healthy controls. Third, this analysis did not take into account other IIEF domains, thus including sexual desire and intercourse satisfaction. Likewise, we did not assess rates of depression or anxiety using validated psychometric tools. Fourth, we decided not to include androgen status and the hormonal milieu because not every patient had a complete laboratory tests profile at his first office visit, which was actually an entry criterion for this study; however, in the subcohort of men with available total testosterone values (n = 174), NLR >3 was still associated with severe ED at multivariable analysis adjusted for testosterone levels (OR [95% CIs] 3.47 [1.10-11.68]). Strengths of this study include the precise assessment of both ED at diagnosis and of patient-related comorbidities at an academic outpatient clinic, as well as the use of a unique centralized test laboratory for the execution of blood tests.
CONCLUSIONS
This exploratory analysis examined for the first time the role of NLR in men with ED. We found that NLR decreases as a function of increasing ED severity. Moreover, we identified NLR >3 as the most informative cutoff for identifying men with severe ED, defined as IIEF-EF score <11. Men with severe ED had a tripled rate of NLR >3 compared to men with non-severe ED. After accounting for established risk factors for decreased erectile function (i.e., older age, comorbidities, obesity, and cigarette smoking), NLR values >3 emerged as an independent predictor of severe ED. The easy availability of this index in the everyday clinical practice, as well as its ability in capturing several aspects of ED pathogenesis, makes NLR a possible candidate for ED risk assessment and stratification.
